Pharnext
ALPHA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0011191287 (+4 more)
- LEI:
- 969500KJGF9ZUYXSMJ27
- Country:
- France
- Address:
- 9 RUE DES FILLES SAINT-THOMAS, 75002 PARIS
- Website:
- http://www.pharnext.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Our company Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical needs. Our drug Candidates Two drug candidates are currently in clinical development: PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A and PXT864 for Alzheimer’s disease. Both of our lead assets originated from the Pleotherapy R&D approach.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-08-27 13:00 |
Legal Proceedings Report
Ouverture d'une procédure de liquidation judiciaire
|
French | 194.1 KB | |
| 2024-08-01 18:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 189.9 KB | |
| 2024-07-18 18:00 |
Capital/Financing Update
Point concernant l'accord de financement en obligations convertibles accordé pa…
|
French | 194.2 KB | |
| 2024-07-15 18:00 |
Legal Proceedings Report
Demande d'ouverture d'une procédure de liquidation judiciaire
|
French | 193.2 KB | |
| 2024-07-10 08:00 |
Capital/Financing Update
Pharnext fait un point sur sa situation financière
|
French | 191.6 KB | |
| 2024-07-04 20:00 |
Legal Proceedings Report
Pharnext annonce la résiliation du contrat de financement accordé par Néovacs
|
French | 232.3 KB | |
| 2024-07-03 08:00 |
Capital/Financing Update
Pharnext fait un point sur les conséquences de sa situation stratégique et fina…
|
French | 208.2 KB | |
| 2024-07-01 18:30 |
Share Issue/Capital Change
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 185.7 KB | |
| 2024-06-28 08:00 |
Legal Proceedings Report
Pharnext fait un point d'étape sur les dernières avancées majeures d'un point d…
|
French | 209.3 KB | |
| 2024-06-18 18:30 |
Post-Annual General Meeting Information
Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 jui…
|
French | 194.9 KB | |
| 2024-06-05 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 181.3 KB | |
| 2024-05-29 18:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 190.9 KB | |
| 2024-05-07 19:10 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 190.6 KB | |
| 2024-05-06 18:00 |
Pre-Annual General Meeting Information
Pharnext convoque ses actionnaires en assemblée générale le 10 juin 2024
|
French | 194.7 KB | |
| 2024-05-02 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 195.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Adocia | France | ADOC | |
|
Advicenne | France | ALDVI | |
|
Aelis Farma | France | AELIS | |
|
Aker BioMarine | Norway | AKBM | |
|
ALK-Abelló | Denmark | ALK | |
|
Alligator Bioscience | Sweden | ATORX | |
|
Alvotech Holdings S.A | Luxembourg | ALVO | |
|
AlzeCure Pharma | Sweden | ALZCUR | |
|
Alzinova AB | Sweden | ALZ | |
| ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. | Türkiye | ANGEN |